Unspecific, broad toxicity against KRAS (MDA-MB-231, MIA PaCa-2) and HRAS mutant (Hs 578T, T24) cancer cell lines, as well as HEK293-EBNA cells, is a major issue of OphA (Figure 6A). This evidence concerns the gene KRAS and cancer.